FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 11th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated [●], 2020, is by and between Ligand Pharmaceuticals Incorporated, a Delaware limited liability company (“Parent”) and [●], a [●], as rights agent (the “Rights Agent”).
AGREEMENT AND PLAN OF MERGER by and among LIGAND PHARMACEUTICALS INCORPORATED, PELICAN ACQUISITION SUB, INC. and PFENEX INC. Dated as of August 10, 2020Agreement and Plan of Merger • August 11th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated August 10, 2020, is by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Parent”), Pelican Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”), and Pfenex Inc., a Delaware corporation (the “Company”). Each of Parent, Acquisition Sub and the Company are sometimes referred to as a “Party.” All capitalized terms that are used in this Agreement but not defined in this Agreement shall have the respective meanings ascribed thereto in Annex A.
